deCODE Announces Departure of Jean-Francois Formela from Board of Directors
News Jan 02, 2006
deCODE genetics has announced that Jean-Francois Formela will be leaving the company’s Board of Directors. Dr. Formela, a Senior Partner at Atlas Venture, has served on deCODE’s board since the formation of the company in 1996 and plans to devote his time to a new Atlas fund.
"Jean-Francois has been a great friend of deCODE since the very beginning," said Kari Stefansson, CEO of deCODE.
"Atlas was a key member of the group of venture firms that got deCODE off the ground almost a decade ago, and since that time Jean Francois has been ready to pitch in with ideas and effort whenever needed."
"We will miss his presence and wealth of experience in our industry. We thank him heartily for his help, hard work and support, and wish him the best in all his future endeavours."
"This was clearly a difficult decision especially as the company continues to gain momentum based on the fruits of its pioneering work in human genetics."
"It has been an exciting journey and I have truly enjoyed working with Kari and his team to realize his vision," said Dr. Formela.
"I wish him and the company continued success as more programs enter the clinic in the coming years."
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE